array(3) { ["company_details"]=> array(13) { ["name"]=> string(35) "Tekla Healthcare Opportunities Fund" ["slug"]=> string(44) "e8566-us-tekla-healthcare-opportunities-fund" ["logo"]=> NULL ["description"]=> string(983) "Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in the United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. It focuses on investing in private companies and other restricted securities, including private investments in public equity and venture capital investments, if these securities would comprise approximately 10% or less of managed assets. It invests in sub-sectors, such as biotechnology, healthcare equipment and supplies, healthcare providers and services, healthcare technology, life sciences tools and services, pharmaceuticals, real estate investment trusts, real estate management and development. Tekla Capital Management LLC is the investment advisor of the Fund." ["address_street"]=> string(17) "2 Liberty Sq FL 9" ["address_place"]=> string(6) "Boston" ["address_region"]=> string(13) "Massachusetts" ["founding_date"]=> string(10) "2014-01-26" ["website_domain"]=> string(12) "teklacap.com" ["website_url"]=> string(24) "https://www.teklacap.com" ["industry_codes"]=> array(1) { [0]=> string(53) "Trusts, Except Educational, Religious, and Charitable" } ["employee_count"]=> int(2) ["article_count"]=> int(145) } ["articles"]=> array(7) { [0]=> array(7) { ["title_en"]=> string(84) "Johnson & Johnson (NYSE:JNJ) Stock Position Raised by Graham Capital Management L.P." ["snippet_en"]=> string(296) "Graham Capital Management L.P. raised its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 108.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,569 shares of the company's stock after acquiring a" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-11-30/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3002266e-8d28-47bf-a243-7dc9f574377a" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2023-11-30" ["categories"]=> array(8) { [0]=> string(20) "Corporate Governance" [1]=> string(12) "Stock Market" [2]=> string(31) "Financial Update/Profit Warning" [3]=> string(18) "General Investment" [4]=> string(14) "Issuing Shares" [5]=> string(16) "Share Repurchase" [6]=> string(11) "Acquisition" [7]=> string(24) "Quarterly/Annual Figures" } } [1]=> array(7) { ["title_en"]=> string(55) "Tekla Healthcare Opportunities Fund's Dividend Analysis" ["snippet_en"]=> string(232) "Using the data from GuruFocus, let's look into Tekla Healthcare Opportunities Fund's dividend performance and assess its sustainability. To assess the sustainability of the dividend, one needs to evaluate the company's payout ratio." ["url"]=> string(91) "https://finance.yahoo.com/news/tekla-healthcare-opportunities-funds-dividend-111310227.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8839185a-41b9-452a-9795-467e7504709b" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-10-18" ["categories"]=> array(1) { [0]=> string(12) "Stock Market" } } [2]=> array(7) { ["title_en"]=> string(72) "Johnson & Johnson (NYSE:JNJ) Shares Bought by RNC Capital Management LLC" ["snippet_en"]=> string(217) "RNC Capital Management LLC raised its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC)." ["url"]=> string(112) "https://www.defenseworld.net/2023/10/09/johnson-johnson-nysejnj-shares-bought-by-rnc-capital-management-llc.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/541f0636-9fd8-491d-8e1a-8da06ab1b9dc" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-10-09" ["categories"]=> array(9) { [0]=> string(18) "Expansion & Growth" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(18) "General Investment" [3]=> string(12) "Stock Market" [4]=> string(14) "Issuing Shares" [5]=> string(11) "Regulations" [6]=> string(16) "Share Repurchase" [7]=> string(11) "Acquisition" [8]=> string(24) "Quarterly/Annual Figures" } } [3]=> array(7) { ["title_en"]=> string(82) "Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)" ["snippet_en"]=> string(300) "Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-09-29/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/28564341-88d3-4b88-b2ed-9009ed96617e" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2023-09-29" ["categories"]=> array(10) { [0]=> string(12) "Stock Market" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(18) "General Investment" [3]=> string(19) "Investment Requests" [4]=> string(24) "Stock Research & Ratings" [5]=> string(14) "Issuing Shares" [6]=> string(11) "Regulations" [7]=> string(16) "Share Repurchase" [8]=> string(11) "Acquisition" [9]=> string(24) "Quarterly/Annual Figures" } } [4]=> array(7) { ["title_en"]=> string(65) "Tekla Healthcare Opportunities Fund (THQ) Declares $0.11 Dividend" ["snippet_en"]=> string(209) "Tekla Healthcare Opportunities Fund said on August 10, 2023 that its board of directors declared a regular monthly dividend of $0.11 per share ($1.35 annualized). Previously, the company paid $0.11 per share." ["url"]=> string(97) "https://www.nasdaq.com/articles/tekla-healthcare-opportunities-fund-thq-declares-$0.11-dividend-1" ["image_url"]=> NULL ["source"]=> string(10) "nasdaq.com" ["publication_date"]=> string(10) "2023-08-12" ["categories"]=> array(1) { [0]=> string(12) "Stock Market" } } [5]=> array(7) { ["title_en"]=> string(109) "Royce Global Value Trust, Ecopetrol S.A., Another 8 Companies Have A High Estimated Dividend Yield | Via News" ["snippet_en"]=> string(299) "(VIANEWS) – Royce Global Value Trust (RGT), Ecopetrol S.A. (EC), Tekla Healthcare Opportunies Fund Shares of Beneficial Interest (THQ) have the highest dividend yield stocks on this list. A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend" ["url"]=> string(114) "https://via.news/markets/royce-global-value-trust-ecopetrol-s-a-another-8-companies-high-estimated-dividend-yield/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bf25d29d-ee04-49c9-918b-82885fd5388e" ["source"]=> string(8) "via.news" ["publication_date"]=> string(10) "2022-12-19" ["categories"]=> array(1) { [0]=> string(12) "Stock Market" } } [6]=> array(7) { ["title_en"]=> string(81) "Tekla Healthcare Opportunities Fund Announces Renewal of Share Repurchase Program" ["snippet_en"]=> string(298) "Tekla Healthcare Opportunities Fund (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period" ["url"]=> string(143) "https://www.morningstar.com/news/business-wire/20230316005679/tekla-healthcare-opportunities-fund-announces-renewal-of-share-repurchase-program" ["image_url"]=> NULL ["source"]=> string(15) "morningstar.com" ["publication_date"]=> NULL ["categories"]=> array(2) { [0]=> string(12) "Stock Market" [1]=> string(16) "Share Repurchase" } } } ["category_annotations"]=> array(25) { [0]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(29) } [1]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(10) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(7) } [3]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(4) } [4]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(4) } [6]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [7]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(3) } [8]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [9]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(18) "Business Structure" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(2) } [13]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [14]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(1) } [15]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(16) "Customer Privacy" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(11) "Slush Funds" ["count"]=> int(1) } } } e8566-us-tekla-healthcare-opportunities-fund